Concepedia

Publication | Open Access

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

198

Citations

28

References

2020

Year

Abstract

ClinicalTrials.gov identifier: NCT03069378.

References

YearCitations

Page 1